![logo](/logos/BDX.webp)
Becton, Dickinson and Company
NYSE:BDX
245.06 (USD) • At close February 5, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Becton, Dickinson and Company |
Symbool | BDX |
Munteenheid | USD |
Prijs | 245.06 |
Beurswaarde | 71,069,360,480 |
Dividendpercentage | 1.58% |
52-weken bereik | 218.75 - 251.99 |
Industrie | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Thomas E. Polen Jr. |
Website | https://www.bd.com |
An error occurred while fetching data.
Over Becton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)
![logo](/logo.webp)